- Home
- DSY vs ICCM Comparison
DSY vs ICCM Comparison
Compare DSY & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSY
- ICCM
- Stock Information
- Founded
- DSY 2020
- ICCM 2006
- Country
- DSY China
- ICCM Israel
- Employees
- DSY N/A
- ICCM N/A
- Industry
- DSY
- ICCM
- Sector
- DSY
- ICCM
- Exchange
- DSY Nasdaq
- ICCM Nasdaq
- Market Cap
- DSY 57.6M
- ICCM 61.1M
- IPO Year
- DSY N/A
- ICCM N/A
- Fundamental
- Price
- DSY $0.87
- ICCM $0.98
- Analyst Decision
- DSY
- ICCM Strong Buy
- Analyst Count
- DSY 0
- ICCM 1
- Target Price
- DSY N/A
- ICCM $2.50
- AVG Volume (30 Days)
- DSY 692.6K
- ICCM 2.5M
- Earning Date
- DSY 01-01-0001
- ICCM 11-25-2025
- Dividend Yield
- DSY N/A
- ICCM N/A
- EPS Growth
- DSY 120.37
- ICCM N/A
- EPS
- DSY 0.01
- ICCM N/A
- Revenue
- DSY $7,323,356.00
- ICCM $2,787,000.00
- Revenue This Year
- DSY N/A
- ICCM $3.95
- Revenue Next Year
- DSY N/A
- ICCM $266.15
- P/E Ratio
- DSY $84.41
- ICCM N/A
- Revenue Growth
- DSY 16.37
- ICCM N/A
- 52 Week Low
- DSY $0.87
- ICCM $0.48
- 52 Week High
- DSY $7.33
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- DSY 34.74
- ICCM 46.89
- Support Level
- DSY $1.20
- ICCM $0.93
- Resistance Level
- DSY $1.08
- ICCM $1.40
- Average True Range (ATR)
- DSY 0.10
- ICCM 0.07
- MACD
- DSY -0.04
- ICCM -0.01
- Stochastic Oscillator
- DSY 0.92
- ICCM 12.45
About DSY Big Tree Cloud Holdings Limited Ordinary Shares
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.